Showing 9 of 9 recruiting trials for “Catastrophic antiphospholipid syndrome”
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
🏥 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.📍 70 sites📅 Started Dec 2025View details ↗
A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 2 sites📅 Started Jul 2025View details ↗
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
👨⚕️ George Triadafilopoulos, Silicon Valley Gastroenterology📍 1 site📅 Started Feb 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →